LENZ
LENZ Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
LENZ Therapeutics, Inc.
3.07
−0.42 · −12.17%
post 3.09 +0.80%
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $23.7M | 11.92% | 0.00% | |
| 2 | Falcon Edge CapitalFalcon Edge Capital | $20.5M | 10.30% | 0.00% | |
| 3 | FMRFMR | $20.2M | 10.15% | −1.08% | |
| 4 | Versant Venture ManagementVersant Venture | $15.1M | 7.58% | 0.00% | |
| 5 | BlackRockBlackRockindex-like | $13.0M | 6.54% | +15.95% | |
| 6 | Squarepoint OpsSquarepoint Ops | $9.9M | 4.98% | +15.97% | |
| 7 | Standard Life AberdeenStandard Life Aberdeen | $8.8M | 4.41% | +33.88% | |
| 8 | Millennium ManagementMillennium | $8.6M | 4.30% | +73.54% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $6.2M | 3.13% | +5.43% | |
| 10 | 72 Investment Holdings72 Investment | $5.8M | 2.90% | 0.00% | |
| 11 | Blue Owl Capital HoldingsBlue Owl Capital | $4.3M | 2.16% | +49.34% | |
| 12 | CAM Group HoldingCAM | $4.0M | 2.00% | 0.00% | |
| 13 | Citadel AdvisorsCitadel | $3.3M | 1.66% | +277.77% | |
| 14 | Geode Capital ManagementGeodeindex-like | $3.2M | 1.61% | +7.64% | |
| 15 | Trexquant InvestmentTrexquant Investment | $2.8M | 1.42% | +132.05% | |
| 16 | Marshall WaceMarshall Wace | $2.8M | 1.41% | +207.68% | |
| 17 | Qube Research & TechnologiesQube Research & Technologies | $2.7M | 1.38% | new | |
| 18 | Morgan StanleyMorgan Stanley | $2.7M | 1.35% | −27.10% | |
| 19 | Primecap ManagementPrimecap | $2.7M | 1.35% | 0.00% | |
| 20 | Tang Capital ManagementTang | $2.6M | 1.29% | 0.00% | |
| 21 | Alyeska Investment GroupAlyeska Investment | $2.5M | 1.25% | −5.31% | |
| 22 | State StreetState Streetindex-like | $2.3M | 1.16% | +1.11% | |
| 23 | Two Sigma InvestmentsTwo Sigma | $1.6M | 0.81% | −43.00% | |
| 24 | Rock Springs Capital ManagementRock Springs | $1.5M | 0.73% | 0.00% | |
| 25 | Bank of AmericaBank of America | $1.5M | 0.73% | −53.35% |
147 managers report $199.2M of LENZ Therapeutics on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; RA Capital Management is largest at 11.92%.
Expected move
Inputsspot 3.05exp Jan 15ATM strike 2.5ATM straddle 1.30IV 122%